Pacifica Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3
Closed -$61 531
2024
Q2
$61 Hold
3
﹤0.01% 527
2024
Q1
$53 Sell
3
-20
-87% -$343 ﹤0.01% 508
2023
Q4
$255 Sell
23
-30
-57% -$408 ﹤0.01% 539
2023
Q3
$860 Buy
53
+50
+1,667% +$1.04K ﹤0.01% 504
2023
Q2
$62 Hold
3
﹤0.01% 477
2023
Q1
$72 Hold
3
﹤0.01% 485
2022
Q4
$84 Sell
3
-5
-63% -$128 ﹤0.01% 462
2022
Q3
$0 Hold
8
﹤0.01% 496
2022
Q2
$0 Hold
8
﹤0.01% 505
2022
Q1
$0 Hold
8
﹤0.01% 493
2021
Q4
$0 Hold
8
﹤0.01% 509
2021
Q3
$0 Buy
+8
New +$256 ﹤0.01% 499

Other funds holding OGN

Pacifica Partners's OGN Position: Q3 2024 in Review

Pacifica Partners sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 3 shares — an estimated $61 sold.

Pacifica Partners first reported a position in OGN in Q3 2021 and held it in 12 quarters. The position peaked at $860 in Q3 2023. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Pacifica Partners reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Pacifica Partners sold 3 Organon & Co shares in Q3 2024, an estimated $61.
  • Pacifica Partners first reported a position in Organon & Co in Q3 2021 and held it in 12 quarters.
  • Pacifica Partners's Organon & Co position peaked at $860 in Q3 2023.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Pacifica Partners's 13F filing for Q3 2024, filed 7 Oct 2024.